Pfizer recalls drug after another drug found in a bottle
Pfizer Inc. initiated a voluntarily recall of two lots of Effexor XR after receiving a report from a pharmacist that one bottle of the company's antidepressant medicine also contained a capsule of another product.
Trending on the Topix Network
Tue Mar 04, 2014
How Rare Disease Know-how Can Shape Big Pharma Clinical Trials
When Andy Lee joined Genzyme from Pfizer, the differences between the companies were staring him in the face.
Mon Mar 03, 2014
Stopping criminal access to APIs must not block generics, says expert
Criminal access to APIs must be cut off in a way that does not infringe generics companies' right to buy chemicals, a top US prosecutor told In-Pharmatechnologist.com.
Vista Partners Updates Coverage On Mast Therapeutics (Nyse MKT: MSTX); Price Target $2.25
Vista Partners announced today that it has updated coverage on Mast Therapeutics Inc. , a publicly traded biopharmaceutical company headquartered in San Diego, CA; and maintains its twelve-month price target of $2.25.
Week in Review: To Stage Hong Kong IPO
More detailsa . Stock Symbols: Help employers find you! Check out all the jobs and post your resume .
Apple's Missteps Could Be BlackBerry's Turnaround
For a long period of time, BlackBerry was the de facto choice for businesses looking for a secure mobile device.
Sun Mar 02, 2014
Wall St. Cheat Sheet
Will Pfizer Bounce Back From Last Year's Levoxyl Shortage?
Pfizer Inc. will again be shipping a thyroid drug that was in short supply last year.
Fri Feb 28, 2014
DIA Announces Internationally Acclaimed Leaders as Co-Chairs of Milestone Meeting
DIA today announced that two worldwide leaders in the pharmaceutical and medical product development will co-chair the DIA 2014 50th Annual Meeting June 15-19 at the San Diego Convention Center.
Tue Feb 25, 2014
Q1 Productions Hosting 3rd Annual Regulatory Writing and Submission Conference
For the third consecutive year, Q1 Productions will be hosting the Regulatory Writing and Submission Conference on May 8-9, 2014 in Alexandria, Virginia, offering medical and regulatory writers and submissions specialists an opportunity to meet with the industry's biggest names and receive the most relevant information pertaining to today's ... (more)
Essex Medipharma To Distribute Pfizer Inc. Glaucoma Eye Drops In China
XalatanA and XalacomA eye drops both treat the high intraocular fluid pressure associated with glaucoma.
Pfizer Given "Buy" Rating at TheStreet
's stock had its "buy" rating reiterated by equities researchers at TheStreet in a research report issued on Tuesday, ARN reports.
Mon Feb 24, 2014
GEA Pharma Systems Release: Continuous Pharmaceutical Processing: Anytime, Anywhere, Interphex
PCMM comprises a system that integrates small footprint, continuous processing equipment, smart control systems and PODs to process API powders and inactive ingredients through to bulk tablets.
Pfizer Announces FDA Approval to Include Radiographic Data on...
Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved a supplemental New Drug Application to update the current label of XELJANZ 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan and ORAL Start .
Pfizer Announces Positive Top-Line Results Of Landmark...
CAPiTA is the largest double-blind, randomized, placebo-controlled vaccine efficacy trial ever conducted in adults.
Thu Feb 20, 2014
Pfizer, MIT want to rethink drug manufacturing
The goal of a collaboration announced today between the Massachusetts Institute of Technology and drug giant Pfizer aims to lower the cost of making the most complex types of biologically-based drugs.
Wed Feb 19, 2014
Teva, Ranbaxy reach settlement on collusion charges
Teva Pharmaceuticals USA and Ranbaxy Pharmaceuticals agreed to pay a $300,000 penalty and terminate a four-year-old deal not to oppose each other's rights to sell dozens of drugs exclusively in the United States under an agreement reached Wednesday with the New York Attorney General's Office.
Tue Feb 18, 2014
The Motley Fool
Can a New Indication for Lyrica Help Results at Pfizer?
Despite having lost exclusivity in the Canadian market in 2013, Lyrica had sales of $4.6 billion, an increase of 11% for the year.
Mon Feb 17, 2014
Investigation Report on China Atorvastatin Market, 2009-2018
Reportstack, provider of premium market research reports announces the addition of Investigation Report on China Atorvastatin Market, 2009-2018 market report to its offering The prevalence rate of abnormal blood lipid in China is lower than that in most developed countries, but the average serum TC level of Chinese people is upgrading for the ... (more)
Thu Feb 13, 2014
Protalix Biotherapeutics - A Compelling Buy Due To Validation Of Oral Protein Delivery Technology
On Feb 12, 2014, Protalix released the highly anticipated Phase I clinical data on its oral drug candidate for Gaucher's disease, PLX-112.
Tue Feb 11, 2014
Pharmarama CEO: 'We are the supply chain'
" Traffic companies " which source medicines for clinical trials are an unsung but essential phase of safe supply chains, according to Pharmarama.